Suchergebnisse
Filter
12 Ergebnisse
Sortierung:
In the Penumbra of the Antillean Hallucination
In: Small axe: a journal of criticism, Band 21, Heft 2, S. 1-20
ISSN: 1534-6714
This intervention in the problem of representation and postcoloniality examines the proliferating newspaper photographs of accused criminals in the former British colony of Nevis. These images instantiate what Frantz Fanon describes as an "autoscopic" hallucination, the effect of a mirror that disorders Antillean imagination and governmentality. However, one finds that Fanon's formulation of the "Antillean hallucination" and the resulting negative assessment of the prospects of an Antillean postcoloniality are the effect of a sticky/tarring alignment with the sensory schisms and epistemic rifts that constitute Lacanian psychoanalysis as an extension of French colonial politics. Recognizing how Jacques Lacan "prepares his own snout" and makes himself a "tar-baby," Griffin offers the grave citation as a ruse for escape. He examines a point of separation in the Lacanian/Fanonian union by identifying in the Antillean hallucination a voice that is not ventriloquized and names that picture an achievable Antillean postcoloniality.
Incendiary Mother: Antigua and the Postcoloniality of Forgiveness
In: Interventions: international journal of postcolonial studies, Band 18, Heft 6, S. 887-907
ISSN: 1469-929X
Immigrant workers and Australian trade unions: participation and attitudes
In: International migration review: IMR, Band 29, Heft 3
ISSN: 0197-9183
Principles of Foreign Trade
In: The Economic Journal, Band 35, Heft 139, S. 456
Vitamin D and COVID-19: evidence and recommendations for supplementation
Vitamin D is a hormone that acts on many genes expressed by immune cells. Evidence linking vitamin D deficiency with COVID-19 severity is circumstantial but considerable—links with ethnicity, obesity, institutionalization; latitude and ultraviolet exposure; increased lung damage in experimental models; associations with COVID-19 severity in hospitalized patients. Vitamin D deficiency is common but readily preventable by supplementation that is very safe and cheap. A target blood level of at least 50 nmol l−1, as indicated by the US National Academy of Medicine and by the European Food Safety Authority, is supported by evidence. This would require supplementation with 800 IU/day (not 400 IU/day as currently recommended in UK) to bring most people up to target. Randomized placebo-controlled trials of vitamin D in the community are unlikely to complete until spring 2021—although we note the positive results from Spain of a randomized trial of 25-hydroxyvitamin D3 (25(OH)D3 or calcifediol) in hospitalized patients. We urge UK and other governments to recommend vitamin D supplementation at 800–1000 IU/day for all, making it clear that this is to help optimize immune health and not solely for bone and muscle health. This should be mandated for prescription in care homes, prisons and other institutions where people are likely to have been indoors for much of the summer. Adults likely to be deficient should consider taking a higher dose, e.g. 4000 IU/day for the first four weeks before reducing to 800 IU–1000 IU/day. People admitted to the hospital with COVID-19 should have their vitamin D status checked and/or supplemented and consideration should be given to testing high-dose calcifediol in the RECOVERY trial. We feel this should be pursued with great urgency. Vitamin D levels in the UK will be falling from October onwards as we head into winter. There seems nothing to lose and potentially much to gain.
BASE
Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research Participants
In: Public health genomics, Band 15, Heft 1, S. 22-30
ISSN: 1662-8063
<i>Background/Aims:</i> To predict the potential public health impact of personal genomics, empirical research on public perceptions of these services is needed. In this study, 'early adopters' of personal genomics were surveyed to assess their motivations, perceptions and intentions. <i>Methods:</i> Participants were recruited from everyone who registered to attend an enrollment event for the Coriell Personalized Medicine Collaborative, a United States-based (Camden, N.J.) research study of the utility of personalized medicine, between March 31, 2009 and April 1, 2010 (n = 369). Participants completed an Internet-based survey about their motivations, awareness of personalized medicine, perceptions of study risks and benefits, and intentions to share results with health care providers. <i>Results:</i> Respondents were motivated to participate for their own curiosity and to find out their disease risk to improve their health. Fewer than 10% expressed deterministic perspectives about genetic risk, but 32% had misperceptions about the research study or personal genomic testing. Most respondents perceived the study to have health-related benefits. Nearly all (92%) intended to share their results with physicians, primarily to request specific medical recommendations. <i>Conclusion:</i> Early adopters of personal genomics are prospectively enthusiastic about using genomic profiling information to improve their health, in close consultation with their physicians. This suggests that early users (i.e. through direct-to-consumer companies or research) may follow up with the health care system. Further research should address whether intentions to seek care match actual behaviors.
Experiential Learning in an Arms Control Simulation
In: PS: political science & politics, Band 41, Heft 2, S. 379-386
ISSN: 0030-8269, 1049-0965
Abstracts
In: Environmental management: an international journal for decision makers, scientists, and environmental auditors, Band 2, Heft 3, S. 265-276
ISSN: 1432-1009